Pubertal development in HIV-infected African children on first-line antiretroviral therapy.

Pubertal development in HIV-infected African children on first-line antiretroviral therapy.

OBJECTIVES: To estimate age at attaining Tanner stages in Ugandan/Zimbabwean HIV-infected children initiating antiretroviral therapy (ART) in older childhood and investigate predictors of delayed puberty, particularly age at ART initiation. DESIGN: Observational analysis within a randomized trial. M...

Description complète

Détails bibliographiques
Auteurs principaux:	Szubert, A, Musiime, V, Bwakura-Dangarembizi, M, Nahirya-Ntege, P, Kekitiinwa, A, Gibb, D, Nathoo, K, Prendergast, A, Walker, A
Format:	Journal article
Langue:	English
Publié:	Lippincott, Williams and Wilkins 2015

Documents similaires

Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.
par: Bwakura-Dangarembizi, M, et autres
Publié: (2015)

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
par: Crook, A, et autres
Publié: (2016)

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.
par: Kekitiinwa, A, et autres
Publié: (2013)

Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years.
par: Musoke, P, et autres
Publié: (2015)

Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and Zimbabwe
par: Prendergast, A, et autres
Publié: (2019)

Virologic response to first-line efavirenz- or nevirapine-based antiretroviral therapy in HIV-infected African children
par: Kekitiinwa, A, et autres
Publié: (2017)

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.
par: Picat, M, et autres
Publié: (2013)

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
par: Bwakura-Dangarembizi, M, et autres
Publié: (2014)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial
par: Szubert, A, et autres
Publié: (2017)

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.
par: Walker, A, et autres
Publié: (2012)

Opportunities for improving the efficiency of paediatric HIV treatment programmes.
par: Revill, P, et autres
Publié: (2015)

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
par: Prendergast, A, et autres
Publié: (2016)

Baseline inflammatory biomarkers identify subgroups of HIV-infected African children with differing responses to antiretroviral therapy
par: Prendergast, A, et autres
Publié: (2016)

Enhanced prophylaxis with antiretroviral therapy for advanced HIV in Africa
par: Hakim, J, et autres
Publié: (2017)

Virologic response to first-line efavirenz- or nevirapine-based anti-retroviral therapy in HIV-infected African children
par: Kekitiinwa, A, et autres
Publié: (2017)

Marginal structural models for repeated measures where intercept and slope are correlated: an application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapy
par: Farmer, R, et autres
Publié: (2020)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
par: Alexander J Szubert, et autres
Publié: (2017-11-01)

Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1.
par: Kasirye, P, et autres
Publié: (2012)

Marginal structural models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapy.
par: Ruth E Farmer, et autres
Publié: (2020-01-01)

Biomarkers of mortality in adults and adolescents with advanced HIV in sub-Saharan Africa
par: Riitho, V, et autres
Publié: (2024)

Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial
par: Kityo, C, et autres
Publié: (2018)

Biomarkers of mortality in adults and adolescents with advanced HIV in sub-Saharan Africa
par: Victor Riitho, et autres
Publié: (2024-06-01)

Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial
par: Mallewa, J, et autres
Publié: (2018)

The impact of viraemia on inflammatory biomarkers and CD4 cell subpopulations in HIV-infected children in sub-Saharan Africa
par: Prendergast, AJ, et autres
Publié: (2021)

Late presentation with HIV in Africa: phenotypes, risk and risk stratification in the REALITY trial
par: Siika, A, et autres
Publié: (2018)

The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children.
par: Musiime, V, et autres
Publié: (2014)

Improved adherence to antiretroviral therapy observed among HIV-infected children whose caregivers had positive beliefs in medicine in Sub-Saharan Africa
par: Abongomera, G, et autres
Publié: (2016)

Monitoring of highly active antiretroviral therapy in HIV infection.
par: Walker, A, et autres
Publié: (2011)

The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa
par: Walker, SM, et autres
Publié: (2020)

The relationship between leadership style and health worker motivation, job satisfaction and teamwork in Uganda
par: Musinguzi C, et autres
Publié: (2018-04-01)

Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial.
par: Cissy Kityo, et autres
Publié: (2018-12-01)

Ethical and legal constraints to children’s participation in research in Zimbabwe: experiences from the multicenter pediatric HIV ARROW trial
par: Bwakura-Dangarembizi Mutsa, et autres
Publié: (2012-07-01)

Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis.
par: Prendergast, A, et autres
Publié: (2011)

Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy
par: Michelle A. Moorhouse, et autres
Publié: (2018-10-01)

Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children
par: Kekitiinwa, A, et autres
Publié: (2016)

Prevalence and correlates of HIV testing among adolescents 10–19 years in a post-conflict pastoralist community of Karamoja region, Uganda
par: Rogers N. Ssebunya, et autres
Publié: (2018-05-01)

Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial.
par: Eva Natukunda, et autres
Publié: (2023-01-01)

Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
par: Prendergast, A, et autres
Publié: (2008)

Once- versus twice-daily abacavir and lamivudine in African children: the randomised controlled ARROW Trial
par: Musiime, V, et autres
Publié: (2016)

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.
par: Musiime, V, et autres
Publié: (2014)